Literature DB >> 33608514

Robust inference of kinase activity using functional networks.

Serhan Yılmaz1, Marzieh Ayati2, Daniela Schlatzer3, A Ercüment Çiçek4,5, Mark R Chance3,6, Mehmet Koyutürk7,3.   

Abstract

Mass spectrometry enables high-throughput screening of phosphoproteins across a broad range of biological contexts. When complemented by computational algorithms, phospho-proteomic data allows the inference of kinase activity, facilitating the identification of dysregulated kinases in various diseases including cancer, Alzheimer's disease and Parkinson's disease. To enhance the reliability of kinase activity inference, we present a network-based framework, RoKAI, that integrates various sources of functional information to capture coordinated changes in signaling. Through computational experiments, we show that phosphorylation of sites in the functional neighborhood of a kinase are significantly predictive of its activity. The incorporation of this knowledge in RoKAI consistently enhances the accuracy of kinase activity inference methods while making them more robust to missing annotations and quantifications. This enables the identification of understudied kinases and will likely lead to the development of novel kinase inhibitors for targeted therapy of many diseases. RoKAI is available as web-based tool at http://rokai.io .

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33608514      PMCID: PMC7895941          DOI: 10.1038/s41467-021-21211-6

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  43 in total

1.  The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture.

Authors:  P Cohen
Journal:  Eur J Biochem       Date:  2001-10

2.  Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

Authors:  James E Butrynski; David R D'Adamo; Jason L Hornick; Paola Dal Cin; Cristina R Antonescu; Suresh C Jhanwar; Marc Ladanyi; Marzia Capelletti; Scott J Rodig; Nikhil Ramaiya; Eunice L Kwak; Jeffrey W Clark; Keith D Wilner; James G Christensen; Pasi A Jänne; Robert G Maki; George D Demetri; Geoffrey I Shapiro
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

3.  DeepKinZero: zero-shot learning for predicting kinase-phosphosite associations involving understudied kinases.

Authors:  Iman Deznabi; Busra Arabaci; Mehmet Koyutürk; Oznur Tastan
Journal:  Bioinformatics       Date:  2020-06-01       Impact factor: 6.937

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator.

Authors:  Danica D Wiredja; Marzieh Ayati; Sahar Mazhar; Jaya Sangodkar; Sean Maxwell; Daniela Schlatzer; Goutham Narla; Mehmet Koyutürk; Mark R Chance
Journal:  Proteomics       Date:  2017-10-25       Impact factor: 3.984

6.  Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.

Authors:  Puneet Puri; Faridoddin Mirshahi; Onpan Cheung; Ramesh Natarajan; James W Maher; John M Kellum; Arun J Sanyal
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

7.  INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases.

Authors:  Robin Beekhof; Carolien van Alphen; Alex A Henneman; Jaco C Knol; Thang V Pham; Frank Rolfs; Mariette Labots; Evan Henneberry; Tessa Ys Le Large; Richard R de Haas; Sander R Piersma; Valentina Vurchio; Andrea Bertotti; Livio Trusolino; Henk Mw Verheul; Connie R Jimenez
Journal:  Mol Syst Biol       Date:  2019-04-12       Impact factor: 11.429

8.  The target landscape of clinical kinase drugs.

Authors:  Susan Klaeger; Stephanie Heinzlmeir; Mathias Wilhelm; Harald Polzer; Binje Vick; Paul-Albert Koenig; Maria Reinecke; Benjamin Ruprecht; Svenja Petzoldt; Chen Meng; Jana Zecha; Katrin Reiter; Huichao Qiao; Dominic Helm; Heiner Koch; Melanie Schoof; Giulia Canevari; Elena Casale; Stefania Re Depaolini; Annette Feuchtinger; Zhixiang Wu; Tobias Schmidt; Lars Rueckert; Wilhelm Becker; Jan Huenges; Anne-Kathrin Garz; Bjoern-Oliver Gohlke; Daniel Paul Zolg; Gian Kayser; Tonu Vooder; Robert Preissner; Hannes Hahne; Neeme Tõnisson; Karl Kramer; Katharina Götze; Florian Bassermann; Judith Schlegl; Hans-Christian Ehrlich; Stephan Aiche; Axel Walch; Philipp A Greif; Sabine Schneider; Eduard Rudolf Felder; Juergen Ruland; Guillaume Médard; Irmela Jeremias; Karsten Spiekermann; Bernhard Kuster
Journal:  Science       Date:  2017-12-01       Impact factor: 47.728

9.  Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability.

Authors:  Edmund H Wilkes; Pedro Casado; Vinothini Rajeeve; Pedro R Cutillas
Journal:  Mol Cell Proteomics       Date:  2017-07-03       Impact factor: 5.911

10.  PTMcode: a database of known and predicted functional associations between post-translational modifications in proteins.

Authors:  Pablo Minguez; Ivica Letunic; Luca Parca; Peer Bork
Journal:  Nucleic Acids Res       Date:  2012-11-28       Impact factor: 16.971

View more
  5 in total

1.  Functional Characterization of Co-Phosphorylation Networks.

Authors:  Marzieh Ayati; Serhan Yılmaz; Mark R Chance; Mehmet Koyuturk
Journal:  Bioinformatics       Date:  2022-06-22       Impact factor: 6.931

2.  Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Authors:  Daniel Zingg; Jinhyuk Bhin; Julia Yemelyanenko; Sjors M Kas; Frank Rolfs; Catrin Lutz; Jessica K Lee; Sjoerd Klarenbeek; Ian M Silverman; Stefano Annunziato; Chang S Chan; Sander R Piersma; Timo Eijkman; Madelon Badoux; Ewa Gogola; Bjørn Siteur; Justin Sprengers; Bim de Klein; Richard R de Goeij-de Haas; Gregory M Riedlinger; Hua Ke; Russell Madison; Anne Paulien Drenth; Eline van der Burg; Eva Schut; Linda Henneman; Martine H van Miltenburg; Natalie Proost; Huiling Zhen; Ellen Wientjens; Roebi de Bruijn; Julian R de Ruiter; Ute Boon; Renske de Korte-Grimmerink; Bastiaan van Gerwen; Luis Féliz; Ghassan K Abou-Alfa; Jeffrey S Ross; Marieke van de Ven; Sven Rottenberg; Edwin Cuppen; Anne Vaslin Chessex; Siraj M Ali; Timothy C Burn; Connie R Jimenez; Shridar Ganesan; Lodewyk F A Wessels; Jos Jonkers
Journal:  Nature       Date:  2022-08-10       Impact factor: 69.504

3.  Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD-Driven AML.

Authors:  Anamarija Pfeiffer; Giulia Franciosa; Marie Locard-Paulet; Ilaria Piga; Kristian Reckzeh; Vidyasiri Vemulapalli; Stephen C Blacklow; Kim Theilgaard-Mönch; Lars J Jensen; Jesper V Olsen
Journal:  Cancer Res       Date:  2022-06-06       Impact factor: 13.312

Review 4.  Shining Light on Protein Kinase Biomarkers with Fluorescent Peptide Biosensors.

Authors:  May C Morris
Journal:  Life (Basel)       Date:  2022-03-31

5.  KSTAR: An algorithm to predict patient-specific kinase activities from phosphoproteomic data.

Authors:  Sam Crowl; Ben T Jordan; Hamza Ahmed; Cynthia X Ma; Kristen M Naegle
Journal:  Nat Commun       Date:  2022-07-25       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.